Globus Medical Inc Class A (GMED)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$58.00

Buy

$65.00

arrow-up$0.43 (+0.73%)

Globus Medical Inc is a medical device company. It operates under two divisions that include innovative fusion and disruptive technology developing products for patients with musculoskeletal disorders for various treatment.
Prices updated at 30 May 2025, 23:39 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.01%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. David C. Paul
CEO
Mr. Daniel T. Scavilla
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
5,300
Head office
2560 General Armistead Avenue
Audubon
United States
19403
mobile
+1 610 930-1800
letter
investors@globusmedical.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. James R. Tobin
Independent Director
0.09m--0.42m-
Dr. John A. DeFord, PhD
Independent Director
0.08m--0.47m-
Mr. Robert Andrew Douglas
Independent Director
0.08m--0.41m-
Mr. Stephen T. Zarrilli
Independent Director
0.08m--0.41m-
Ms. Ann D. Rhoads
Independent Director
0.11m--0.44m-
Mr. Daniel T. Lemaitre
Independent Director
0.09m--0.42m-
Ms. Leslie V. Norwalk, Esq.
Independent Director
0.08m--0.41m-
Mr. David D. Davidar
Independent Director
0.09m--0.42m-
Mr. David C. Paul
Executive Chairman of the Board
0.46m--3.06m-
Mr. Daniel J. Wolterman
Independent Director
0.08m--0.41m-
Mr. Daniel T. Scavilla
Director, President and Chief Executive Officer
0.48m--4.86m-
Mr. Keith W. Pfeil
Chief Accounting Officer, Chief Operating Officer and Chief Financial Officer
0.46m--2.36m-
Ms. Kelly G. Huller
Executive Vice President, General Counsel and Corporate Secretary
0.36m--1.63m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc10,909,0820.01444452480.41650130 Apr 20258.06
BlackRock Inc10,723,9110.01649870680.81855130 Apr 20257.92
HHG PLC7,006,2230.278613914115.9171930 Apr 20255.18
BlackRock Fund Advisors6,416,1573.97946-1102698-30 Apr 20254.74
Janus Capital Management LLC5,188,6318.1027769595-30 Apr 20253.83

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
02 Dec 2024-Ms. Kelly G. Huller24.2160,5252,500--
02 Dec 2024-Ms. Kelly G. Huller87.00217,502---
02 Dec 2024-Ms. Kelly G. Huller-----
21 Nov 2024-Lemaitre Dan65.05863,73413,278--
21 Nov 2024-Lemaitre Dan--1,722--
22 Nov 2024-Lemaitre Dan85.0293,263---
22 Nov 2024-Lemaitre Dan65.0571,3601,097--
21 Nov 2024-Lemaitre Dan85.001,128,630---
22 Nov 2024-Lemaitre Dan--625--
22 Nov 2024-Mr. David D. Davidar85.00573,435165,967--
22 Nov 2024-Mr. David D. Davidar85.00575,135516,275--
21 Nov 2024-Mr. David D. Davidar85.001,126,590172,713--
21 Nov 2024-Mr. David D. Davidar85.001,124,890523,041--
21 Nov 2024-Mr. Daniel T. Scavilla43.583,486,400130,000--
21 Nov 2024-Mr. Daniel T. Scavilla-----
21 Nov 2024-Mr. Daniel T. Scavilla-----
21 Nov 2024-Mr. Daniel T. Scavilla85.0011,050,000---
21 Nov 2024-Mr. Daniel T. Scavilla43.772,188,50050,000--
15 Nov 2024-Mr. David C. Paul-----
15 Nov 2024-Mr. David C. Paul24.10627,61226,042--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.